Scientific article
Open access

Angiologie-hémostase - Année 2021 : morceaux choisis

Published inRevue médicale suisse, vol. 18, no. 764-765, p. 18-20
Publication date2022-01-19

Several topics among those that marked the year 2021 are discussed in this article. Factor XI represents an original target for new anticoagulants, and the first results of a phase 2 study of prophylaxis after knee replacement surgery are very promising. A real-life study confirms that the pulmonary embolism exclusion strategy using an age-adjusted D-dimer cut-off is safe and increases the diagnostic yield. Several studies of tranexamic acid provide further insight into the indications for its use and highlight some potential risks. Finally, the concerns regarding a potential risk of increased mortality related to paclitaxel-eluting technology used in lower limb revascularisation are questioned by the results of the latest trials.

  • Anticoagulants / therapeutic use
  • Cardiology
  • Fibrin Fibrinogen Degradation Products
  • Hemostasis
  • Humans
  • Pulmonary Embolism
Citation (ISO format)
FONTANA, Pierre et al. Angiologie-hémostase - Année 2021 : morceaux choisis. In: Revue médicale suisse, 2022, vol. 18, n° 764-765, p. 18–20. doi: 10.53738/REVMED.2022.18.764-65.18
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/04/2023 1:03:45 PM
First validation01/17/2024 12:24:09 PM
Update time01/17/2024 12:24:09 PM
Status update01/17/2024 12:24:09 PM
Last indexation05/06/2024 5:45:43 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack